The RWD & RWE Podcast

Ep 203 [11 February 2026]: Tom Dougherty MBA cDHSc – Does it fit? Expectations for RWD-driven evidence in 2026

Ep 203 [11 February 2026]: Tom Dougherty MBA cDHSc who leads RWD Strategy for Novo Nordisk – We discussed Tom's unique background and the importance of precision in the use and deployment of RWD to support evidentiary use cases. Often referred to as "fit-for-purpose" in selection of RWD, we focused on industry stakeholders and their expectations as we progress in 2026 and beyond."Credibility is the currency, and credibility starts with the discipline thinking!" - TomTom's original episode, #102 was from our podcast on June 14th, 2023.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 202 [28 January 2026]: Jeremy Brody – RWD & RWE: What can we expect for Life Sciences in 2026

Ep 202 [28 January 2026]: Jeremy Brody, Managing Director of Brody Capital & Advisors – We discussed Jeremy's unique background and discussed the evolving RWD/RWE landscape of the last couple years and insights to 2026. Note past episodes with Jeremy, #6 (May 5, 2021) and #86 (February 15, 2023) can be accessed from the link below.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 201 [21 January 2026]: Julia Komissarchik MSc – Security is not privacy! Considerations for RWD use

Ep 201 [21 January 2026]: Julia Komissarchik MSc, Co-Founder & CEO of Glendor, as well as data privacy and de-identification SME – We discussed Julia's unique background and the major considerations for removal of personal health information (PHI) from RWD to support RWE use cases.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 200 [07 January 2026]: 200th RWW with David Thompson PhD, RWE thought-leader - The ROI of RWE: Quantifying Value Amidst the Buzz of RWE

Ep 200 [January 2026]: 200th RWW! Conversation with David Thompson PhD, RWE thought-leader – We discussed Dave's unique perspective on the RWE and Life Sciences industry as it is today. Also, as an update to David's original episode on RWW back on 24 May 2023 (episode100), Dave offered his reflections on the ROI of RWE, describing the work he is leading to quantify the ROI of RWE as applied to various RWE use cases. Going beyond the buzz and expectations to quantified value..Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 199 [17 December 2025]: Dan O'Connor – Real World Data in the Real World Capital Market, Part II

Ep 199 [17 December 2025]: Dan O'Connor MBA, Founder-Operator and investor, and Managing Partner at Contour Ridge – We discussed Dan's unique background and we had an interactive conversation on the RWD/RWE market, trends, and future as an update to Dan's original episode on RWW back on 28 June 2023 (episode104).Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 198 [10 December 2025]: Ryan Tarzy – Real World Imaging Data: Seeing the full picture for RWD

Ep 198 [10 December 2025]: Ryan Tarzy, Founder and CEO of Avandra – We discussed Ryan's unique background and we explored why now is the time for Real World Imaging Data, and how imaging data is transforming the RWD marketplace (such as in Cardiology).Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 197 [03 December 2025]: Shaun Rowark – RWD in the UK: Is data catching up with technology?

Ep 197 [03 December 2025]: Shaun Rowark, Associate Director for Healthcare Data Analytics at the UK's National Institute for Health and Care Excellence (NICE) – We dove into the UK's healthcare data revolution, with insights on Secure Data Environments (SDEs) and the more recent Health Data Research Service (HDRS). We explored other initiatives such as the Federated Data Platform, Single Patient Record and the NHS App, while examining Europe's parallel Health Data Space. We also discussed NICE's pioneering use of real-world data in medicines evaluation, as well as using data for guideline development and implementation.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 196 [19 November 2025]: Nathan Markward PhD MPH – RWD: How it defines then accelerates precision research

Ep 196 [19 November 2025]: Nathan Markward PhD MPH, Chief Research Officer at PurpleLab – We discussed precision medicine from concept to application, covering fundamental principles and implementation across the pharmaceutical R&D lifecycle. The discussion examined how RWD helps define and integrate with precision medicine, as we discuss some current industry trends, key challenges, and future directions shaping the evolution of personalized healthcare.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 195 [12 November 2025]: Derk Arts MD PhD – Driven to provide evidence: Era of the self-driven study

Ep 195 [12 November 2025]: Derk Arts MD PhD, Founder & CEO of Castor – We discussed the current life science business environment and how AI-powered automation can support EMR/claims data access and rapid RWE generation.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 194 [05 November 2025]: Wendy Turenne MS – RWD: All grown up now? Companies on the RWD maturity curve

Ep 194 [05 November 2025]: Wendy Turenne MS, former CDO of Aetion and industry consultant – We discussed her perspective on the evolution of the RWD-RWE market and life science company's readiness to address the use cases of tomorrow.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.